News

JumpStart Ventures' NEXT Fund III Starts with Strong Funding

JumpStart Ventures' NEXT Fund III Starts with Strong Funding

JumpStart Ventures Sets a Bold New Course with NEXT Fund III

JumpStart Ventures has made an impressive stride by announcing its successful first close of NEXT Fund III. This initiative has raised nearly $25 million, inching closer to its ambitious $50 million target. The fund is reinforced by the State Small Business Credit Initiative and a consortium of institutional and private investors, showcasing JumpStart Ventures' unwavering dedication to empowering technology founders with essential capital for scaling their innovative startups.

Enhancing Investment in Innovative Startups

NEXT Fund III is dedicated to investing in early-stage Seed and Series A startups. This initiative builds upon JumpStart Ventures' rich history of two decades in supporting high-growth startups. The organization is renowned for providing risk capital and fostering remarkable returns for their investment partners, making a significant impact in the entrepreneurial landscape.

Continuous Funding for Challenging Ventures

This fund marks the third within JumpStart Ventures' NEXT model and stands as its eighth overall venture capital fund. The firm is on a trajectory to maintain its momentum in financing emerging startups, significantly contributing to the region's technology ecosystem.

Expert Insights on Future Growth

“This close symbolizes a tremendous leap forward in nurturing our community's most driven founders,” remarked Hardik Desai, Managing Partner of JumpStart Ventures. “With the support of dedicated partners, we are committed to delivering the necessary capital and resources that will help innovators in scaling their businesses and pioneering transformative technologies.”

A Flourishing Portfolio of Successful Startups

In recent years, JumpStart Ventures' portfolio has invigorated the local venture capital ecosystem. The organization has supported numerous startups such as Abre, Centerline Biomedical, OnStation, Cleveland Diagnostics, Orthobrain, Axuall, and Onshift among others. More than 30 noteworthy portfolio companies, including CoverMyMeds, Able Software, Wireless Environment, CardioInsight, and Vizzle, have successfully exited, yielding substantial profits for their investors.

The Commitment to Startup Growth

JumpStart Ventures manages an impressive array of four distinct investment funds aimed at propelling startup growth. They pair stage-appropriate capital with invaluable connections and partnerships. As one of the most vigilant early-stage investors in Ohio, the organization's investment operations have consistently produced top quartile returns, marked by noted successful exits and fundraising efforts. With NEXT Fund III, JumpStart Ventures intends to invest in approximately 15 startups in the upcoming years.

About JumpStart Ventures

JumpStart Ventures is a venture capital firm that focuses on investing in technology startups at the Seed and Series A stages across Ohio and adjoining areas. With over $200 million managed, the firm offers a seamless continuum of capital to founders navigating critical growth hurdles. For further information, please visit JumpStart.VC.

Frequently Asked Questions

What is NEXT Fund III?

NEXT Fund III is a venture fund established by JumpStart Ventures, aimed at investing in Seed and Series A-stage startups.

How much capital has JumpStart Ventures raised for NEXT Fund III?

JumpStart Ventures has successfully raised nearly $25 million for NEXT Fund III, towards a target of $50 million.

What types of startups will NEXT Fund III invest in?

NEXT Fund III focuses on investing in innovative Seed and Series A technology startups.

What is the goal of JumpStart Ventures?

The primary goal of JumpStart Ventures is to support tech founders in scaling their startups through critical investment and resources.

How many startups does JumpStart Ventures plan to invest in with NEXT Fund III?

JumpStart Ventures intends to invest in about 15 startups through NEXT Fund III in the coming years.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 42

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 4

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 7

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
Venue Two Eleven: Historic Charm Meets Modern Events

Updated Category News Views 5

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

Continue Reading
Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Updated Category News Views 5

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

Continue Reading
Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

Updated Category News Views 9

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 44

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Updated Category News Views 2

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

Continue Reading
U.S. Millionaire Surge: Market Waves or Mirage?

Updated Category News Views 1

Flashing Billions: Minting Millionaires at Breakneck Speed It sounds like something out of an 80s movie: every single day, over 1,200 folks in the United States become millionaires. Yep, you heard right. The UBS Global Wealth Report 2026 threw that number out, and it sure caught my attention. It's not everyday you hear about the U.S. cranking out millionaires like they're...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 61

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Akeso Reports Progress with Ivonescimab in Cancer Treatment

Updated Category News Views 232

Akeso Moves Forward with Promising Cancer Therapy Trials Akeso Biopharma is excited to share fantastic news regarding its latest clinical endeavors in the realm of cancer treatment. The company has successfully enrolled the first patient in the AK112-309 trial, a pivotal Phase III study designed to evaluate the efficacy of ivonescimab in combination with another regimen...

Continue Reading
Quanex Building Products Raises Dividend for Shareholders

Updated Category News Views 168

Quanex Building Products Announces Quarterly Dividend HOUSTON — Quanex Building Products Corporation (NX) is pleased to announce that its Board of Directors declared a quarterly cash dividend of $0.08 per share on its common stock. This dividend is scheduled to be paid to shareholders of record on a specified date, indicating the company's commitment to rewarding its...

Continue Reading
Trump Calls for Transparency from COVID Drug Manufacturers

Updated Category News Views 204

Trump Demands Drug Firms Reveal COVID Vaccine Data Former President Donald Trump has issued a call to pharmaceutical companies to provide concrete evidence regarding the effectiveness of their COVID-19 drugs, particularly emphasizing the need for transparency surrounding their vaccine data. Transparency in Pharmaceuticals On his social media platform, Trump urged these...

Continue Reading
AECOM Technology Sees Stock Surge to Record $108.26 High

Updated Category News Views 106

AECOM Technology Stock Peaks at $108.26 AECOM Technology Corporation has recently achieved a major milestone in the stock market, reaching an impressive high of $108.26. This achievement not only reflects the robust growth of the infrastructure consulting firm but also represents a 43.14% increase in its stock value over the past year. Investors have been showing strong...

Continue Reading
China's Return to US Soybean Purchases Sparks Market Optimism

Updated Category News Views 678

China Resumes U.S. Soybean Purchases Amid Market Changes Recent reports indicate that China has made its initial purchase of U.S. soybeans from the current year’s harvest, marking the end of a prolonged boycott. This significant development comes just ahead of a highly anticipated summit between U.S. President Donald Trump and Chinese President Xi Jinping. Market...

Continue Reading